Instinct Bio Technical Company Holdings Inc

Aktienanalyse zu Instinct Bio Technical Company Holdings Inc (BIOT)

$0.228

-0.039 (-17.16%)Zum Schluss

Loading chart…
Hoch
0.307
Eröffnung
0.283
Volumengewichteter Durchschnittskurs
0.25
Volumen
1.05M
Marktkap.
—
Tief
0.227
Umsatz
267.15K
EV/EBITDA, TTM
0.00

Instinct Bio Technical Company Holdings Inc. is a vertically integrated biotechnology holding company that works in stem cell and regenerative medicine-related fields, wellness and beauty. It operates through subsidiaries. The core activities include research and development in regenerative stem cell cosmetics that focus on regenerative stem cell technology for advanced skincare and personal care formulations, raw materials and supply chain management including procurement, distribution and logistics of raw materials essential for stem cell-conditioned media, original equipment manufacturer and original design manufacturer (OEM/ODM) cosmetic products provision, brand franchising, branding and creative design solutions provision, influencer and celebrity brand collaborations and e-commerce platforms operation. Its product categories include skincare, body and hair care, inner care and supplements, and professional line. Its brands include MANOROL, HAKUA, VIVEA, GENREVER and others.

instinct-biot.com

KI-Analyse of Instinct Bio Technical Company Holdings Inc (BIOT)

Verkaufen

Given the current price of $0.23 and an RSI of 9.446, which indicates extreme oversold conditions, this asset is not a good buy right now due to significant downward momentum and lack of positive catalysts.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Instinct Bio Technical Company Holdings Inc (BIOT) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von .

Erwartetes KGV

5J-Durchschnitt P/E
Aktuelles P/E
0.00

Erwartetes EV/EBITDA

5J-Durchschnitt EV/EBITDA
Aktuelles EV/EBITDA
0.00

Erwartetes KUV

5J-Durchschnitt P/S
Aktuelles P/S
0.00

BIOT FAQ – beantwortet von Alphio AI

Instinct Bio Technical Company Holdings Inc. is a vertically integrated biotechnology holding company that works in stem cell and regenerative medicine-related fields, wellness and beauty. It operates through subsidiaries. The core activities include research and development in regenerative stem cell cosmetics that focus on regenerative stem cell technology for advanced skincare and personal care formulations, raw materials and supply chain management including procurement, distribution and logistics of raw materials essential for stem cell-conditioned media, original equipment manufacturer and original design manufacturer (OEM/ODM) cosmetic products provision, brand franchising, branding and creative design solutions provision, influencer and celebrity brand collaborations and e-commerce platforms operation. Its product categories include skincare, body and hair care, inner care and supplements, and professional line. Its brands include MANOROL, HAKUA, VIVEA, GENREVER and others. It operates in the Consumer Non-Cyclicals sector.

Given the current price of $0.23 and an RSI of 9.446, which indicates extreme oversold conditions, this asset is not a good buy right now due to significant downward momentum and lack of positive catalysts.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln